Почетна › Карцином ендометријума › Пенсилванија › Pittsburgh
Kliničke studije za Карцином ендометријума u gradu Pittsburgh, PA
24 studija za Карцином ендометријума traži učesnike na lokacijama u gradu Pittsburgh i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Тражи се учесникФаза 2
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC-Saint Margaret, Pittsburgh
- UPMC-Mercy Hospital, Pittsburgh
- и још 12
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Тражи се учесникФаза 2
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC Hillman Cancer Center, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
- и још 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Тражи се учесникФаза 3
- AHN West Penn Hospital ( Site 6006), Pittsburgh
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Тражи се учесникФаза 3
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
- UPMC Cancer Center-Washington, Washington · 23 ми удаљено
- и још 1
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Тражи се учесникФаза 1/2
- Allegheny Health Network, Pittsburgh
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Тражи се учесникФаза 1
- University of Pittsburgh Medical Center, Pittsburgh
Distance-Based Exercise to Preserve Function and Prevent Disability
Тражи се учесник
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC Hillman Cancer Center, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
- и још 2
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Тражи се учесникФаза 1
- University of Pittsburgh Medical Center, Pittsburgh
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Тражи се учесникФаза 1
- UPMC, Pittsburgh
A Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer in Adjuvant Setting
Тражи се учесникФаза 3
- Western Pennsylvania Hospital, Pittsburgh
A Phase 1 Study of the Safety and Tolerability of CTX-10726
Тражи се учесникФаза 1
- UPMC Hillman Cancer Center, Pittsburgh
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Тражи се учесникФаза 1/2
- Research Site, Pittsburgh
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Тражи се учесникФаза 3
- Research Site, Pittsburgh
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Тражи се учесникФаза 1
- UPMC Hillman Cancer Center, Pittsburgh
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Тражи се учесникФаза 1/2
- University of Pittsburgh Medical Center, Pittsburgh
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Тражи се учесникФаза 1/2
- Allegheny Health Network, Pittsburgh
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Тражи се учесникФаза 1/2
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
Тражи се учесникФаза 2
- West Penn Hospital, Pittsburgh
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Тражи се учесникФаза 3
- Research Site, Pittsburgh
- Research Site, Pittsburgh
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Тражи се учесникФаза 2
- 127, Pittsburgh
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
Тражи се учесникФаза 2
- West Penn Allegheny Health, Pittsburgh
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
Тражи се учесникФаза 2
- West Penn Hospital, Pittsburgh
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
Тражи се учесникФаза 2
- Allegheny Health, Pittsburgh
Studije za Карцином ендометријума u drugim gradovima
- Houston, TX69 студија
- New York City, NY54 студија
- Boston, MA51 студија
- Arlington, VA41 студија
- Nashville, TN38 студија
- Los Angeles, CA35 студија
- St. Louis, MO29 студија
- Philadelphia, PA29 студија
- Oklahoma City, OK28 студија
- San Antonio, TX27 студија
- Queens, NY26 студија
- Dallas, TX25 студија
Ostale studije u gradu Pittsburgh
- Немалоклетни карцином плућа47 студија
- Рак (све врсте)42 студија
- Рак дојке42 студија
- Рак јајника32 студија
- Колоректални карцином31 студија
- Метастатски карцином31 студија
- Меланом31 студија
- Рак плућа24 студија
- Плоскоклеточни карцином главе и врата23 студија
- Рак простате23 студија
- Депресија22 студија
- Шлог21 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.